Product Images Unasyn

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Unasyn NDC 0049-0024 by Roerig, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - unasyn bulk 01

Chemical Structure - unasyn bulk 01

Chemical Structure - unasyn bulk 02

Chemical Structure - unasyn bulk 02

Logo - unasyn bulk 03

Logo - unasyn bulk 03

This is a listing for a pharmaceutical product called "Injectables", which is distributed by Roerig, a division of Pfizer Inc, based in New York City. It is likely a medication administered through injection.*

PRINCIPAL DISPLAY PANEL - 15 g Bulk Vial Label - unasyn bulk 04

PRINCIPAL DISPLAY PANEL - 15 g Bulk Vial Label - unasyn bulk 04

This appears to be the label information of a prescription drug called Unasyn. Unasyn contains a combination of ampicillin and sulbactam sodium and is intended for intravenous use. The product comes in a sterile 15g container and is labeled with NDC number 0049-0024-28. The label also includes a product code 51744221 and a manufacturer location of New York, NY 10017.*

PRINCIPAL DISPLAY PANEL - 15 g Bottle Carton - unasyn bulk 05

PRINCIPAL DISPLAY PANEL - 15 g Bottle Carton - unasyn bulk 05

This is a description of a pharmacy bulk package of Unasyn, which contains ampicillin sodium and sulbactam sodium with a total volume of 15g. The package is not intended for direct infusion and requires reconstitution with sterile water. The recommended storage for the package is at or below 86°F (0°C). After reconstitution, the solution may be stored for up to 2 hours at room temperature and up to 4 hours if refrigerated. The solution should be discarded if its usage exceeds these time periods. It is advised to use aseptic technique for reconstitution and to transfer the solution to appropriate intravenous infusion devices under sterile conditions.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.